BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25642116)

  • 1. Use of personalized Dynamic Treatment Regimes (DTRs) and Sequential Multiple Assignment Randomized Trials (SMARTs) in mental health studies.
    Liu Y; Zeng D; Wang Y
    Shanghai Arch Psychiatry; 2014 Dec; 26(6):376-83. PubMed ID: 25642116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.
    Liu Y; Wang Y; Kosorok MR; Zhao Y; Zeng D
    Stat Med; 2018 Nov; 37(26):3776-3788. PubMed ID: 29873099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesizing independent stagewise trials for optimal dynamic treatment regimes.
    Chen Y; Wang Y; Zeng D
    Stat Med; 2020 Dec; 39(28):4107-4119. PubMed ID: 32804414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating randomized and observational studies to estimate optimal dynamic treatment regimes.
    Batorsky A; Anstrom KJ; Zeng D
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38804219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian set of best dynamic treatment regimes: Construction and sample size calculation for SMARTs with binary outcomes.
    Artman WJ; Johnson BA; Lynch KG; McKay JR; Ertefaie A
    Stat Med; 2022 Apr; 41(9):1688-1708. PubMed ID: 35124836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive randomization in a two-stage sequential multiple assignment randomized trial.
    Wang J; Wu L; Wahed AS
    Biostatistics; 2022 Oct; 23(4):1182-1199. PubMed ID: 34052847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size calculation based on precision for pilot sequential multiple assignment randomized trial (SMART).
    Yan X; Ghosh P; Chakraborty B
    Biom J; 2021 Feb; 63(2):247-271. PubMed ID: 32529788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulating sequential multiple assignment randomized trials to generate optimal personalized warfarin dosing strategies.
    Rich B; Moodie EE; Stephens DA
    Clin Trials; 2014 Aug; 11(4):435-444. PubMed ID: 24464036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.
    Zhao YQ; Zeng D; Laber EB; Kosorok MR
    J Am Stat Assoc; 2015; 110(510):583-598. PubMed ID: 26236062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Analysis Considerations for Comparing Dynamic Treatment Regimens with Binary Outcomes from Sequential Multiple Assignment Randomized Trials.
    Kidwell KM; Seewald NJ; Tran Q; Kasari C; Almirall D
    J Appl Stat; 2018; 45():1628-1651. PubMed ID: 30555200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size estimation for comparing dynamic treatment regimens in a SMART: A Monte Carlo-based approach and case study with longitudinal overdispersed count outcomes.
    Yap J; J Dziak J; Maiti R; Lynch K; McKay JR; Chakraborty B; Nahum-Shani I
    Stat Methods Med Res; 2023 Jul; 32(7):1267-1283. PubMed ID: 37167008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying a set that contains the best dynamic treatment regimes.
    Ertefaie A; Wu T; Lynch KG; Nahum-Shani I
    Biostatistics; 2016 Jan; 17(1):135-48. PubMed ID: 26243172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMART designs in cancer research: Past, present, and future.
    Kidwell KM
    Clin Trials; 2014 Aug; 11(4):445-456. PubMed ID: 24733671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing dynamic treatment regimes using repeated-measures outcomes: modeling considerations in SMART studies.
    Lu X; Nahum-Shani I; Kasari C; Lynch KG; Oslin DW; Pelham WE; Fabiano G; Almirall D
    Stat Med; 2016 May; 35(10):1595-615. PubMed ID: 26638988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian inference for optimal dynamic treatment regimes in practice.
    Rodriguez Duque D; Moodie EEM; Stephens DA
    Int J Biostat; 2023 Nov; 19(2):309-331. PubMed ID: 37192544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative incidence regression for dynamic treatment regimens.
    Chen LW; Yavuz I; Cheng Y; Wahed AS
    Biostatistics; 2020 Apr; 21(2):e113-e130. PubMed ID: 30371745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating participants' welfare into sequential multiple assignment randomized trials.
    Wang X; Deliu N; Narita Y; Chakraborty B
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38364800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping review of studies using observational data to optimise dynamic treatment regimens.
    Mahar RK; McGuinness MB; Chakraborty B; Carlin JB; IJzerman MJ; Simpson JA
    BMC Med Res Methodol; 2021 Feb; 21(1):39. PubMed ID: 33618655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Power analysis in a SMART design: sample size estimation for determining the best embedded dynamic treatment regime.
    Artman WJ; Nahum-Shani I; Wu T; Mckay JR; Ertefaie A
    Biostatistics; 2020 Jul; 21(3):432-448. PubMed ID: 30380020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach to assess dynamic treatment regimes embedded in a SMART with an ordinal outcome.
    Ghosh P; Yan X; Chakraborty B
    Stat Med; 2023 Mar; 42(7):1096-1111. PubMed ID: 36726310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.